GO:0000400 four-way junction DNA binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0000400 (four-way junction DNA binding) describes the molecular function of binding to a DNA segment containing four-way junctions, also known as Holliday junctions, where two DNA double strands are held together by reciprocal exchange of two of the four strands.
• Four-way junction DNA binding is a common property of architectural proteins, including high-mobility group (HMG) box proteins and other chromatin-associated factors.
• Holliday junction resolvases are enzymes that specifically recognize and cleave four-way junctions, and their activity is essential for homologous recombination and DNA repair.
• Bacteriophage lambda site-specific recombination provides a paradigm for understanding how proteins bind and process four-way junction DNA during genetic recombination.
• The structure of the four-way DNA junction and its interaction with proteins has been characterized in detail, revealing both sequence-independent and sequence-specific binding modes.
• Experimental methods such as native gel electrophoresis, FRET, and X-ray crystallography are used to analyze non-canonical three- and four-way DNA junctions and their protein complexes.
Description
Four-way junction DNA binding (GO:0000400) is a molecular function that enables proteins to recognize and bind to Holliday junctions, which are branched DNA structures formed during homologous recombination and DNA repair. These junctions consist of two DNA double helices held together by the reciprocal exchange of two strands, creating a four-way junction that must be processed by specialized proteins. The ability to bind four-way junctions is not limited to recombinases; it is also a property of architectural proteins such as HMG-box proteins, which bend and distort DNA to facilitate higher-order nucleoprotein assemblies. Understanding this function is critical for dissecting mechanisms of genetic recombination, DNA damage repair, and genome stability. Moreover, four-way junction DNA binding has emerged as a target for biosensing applications, including the detection of tumor-derived exosomes. Researchers studying this term can leverage structural and biochemical approaches to elucidate how proteins recognize and process Holliday junctions [3, 8].
four-way junction DNA binding At A Glance
| GO ID | GO:0000400 |
|---|---|
| GO term | four-way junction DNA binding |
| Ontology | molecular_function |
| Synonym | forked DNA binding, Holliday junction binding |
| Major function | Binding to Holliday junctions to enable recombination, repair, and architectural roles |
| Definition source | QuickGO |
| Related processes | Homologous recombination, DNA repair, site-specific recombination |
| Example proteins | HMG-box proteins, Holliday junction resolvases, lambda integrase |
What Is GO:0000400?
Four-way junction DNA binding is the molecular function of selectively interacting with a DNA segment that contains a four-way junction, also known as a Holliday junction. This structure arises when two DNA double strands are held together by the reciprocal exchange of two of the four strands, one strand from each of the two original helices. Proteins with this function recognize the unique geometry and electrostatic properties of the junction, often without sequence specificity, to facilitate processes such as recombination, repair, and DNA packaging [1, 5].
Why Is four-way junction DNA binding Important in Cell Biology?
Four-way junction DNA binding is essential for maintaining genome integrity because Holliday junctions are central intermediates in homologous recombination and DNA double-strand break repair. Defects in proteins that bind or process these junctions can lead to genomic instability, cancer predisposition, and developmental disorders. Additionally, architectural proteins that bind four-way junctions play roles in chromatin organization and gene regulation. The study of this function also informs biotechnology, as four-way junction DNA has been exploited in biosensors for exosome detection and in the design of supramolecular recognition tools.
• Enables homologous recombination and DNA double-strand break repair by facilitating Holliday junction processing.
• Contributes to genome stability and prevents chromosomal rearrangements.
• Architectural proteins with this activity modulate chromatin structure and gene expression.
• Provides a basis for understanding bacteriophage lambda site-specific recombination.
• Informs the development of biosensors for tumor-derived exosomes.
• Guides the design of synthetic molecules that recognize four-way junctions.
• Supports structural studies of protein-DNA complexes using X-ray crystallography and FRET [3, 8].
• Relevant to cancer biology due to roles in DNA repair pathways.
• Facilitates the analysis of non-canonical DNA junctions in vitro.
• Offers a target for therapeutic intervention in recombination-related diseases.
Molecular Mechanism of four-way junction DNA binding
Recognition of the Holliday junction structure
In simple terms: Proteins that bind four-way junctions recognize the unique cross-shaped DNA structure.
The four-way DNA junction adopts a stacked-X conformation in solution, where the helical arms are paired in a coaxial manner. Proteins that bind this structure often interact with the junction's central region, which is characterized by a widened minor groove and increased electrostatic potential. Binding can be sequence-independent, as seen with architectural proteins like HMG-box factors, or sequence-specific, as with some resolvases [1, 5].
Binding modes and conformational changes
In simple terms: Upon binding, proteins may bend or distort the junction to facilitate their function.
Structural studies of T7 endonuclease I bound to a four-way junction reveal that the protein induces a sharp kink in the DNA, remodeling the junction to position the scissile phosphates for cleavage. Similarly, HMG-box proteins bind four-way junctions with high affinity and induce bends that can be detected by gel electrophoresis and FRET. These conformational changes are critical for the biological roles of these proteins in recombination and chromatin remodeling [1, 5].
Catalytic processing by resolvases
In simple terms: Some proteins not only bind but also cut the four-way junction to resolve it.
Holliday junction resolvases are enzymes that specifically bind and cleave four-way junctions, resolving them into two duplex DNA molecules. These enzymes often use a divalent metal ion cofactor to catalyze phosphodiester bond cleavage. The binding step is essential for proper positioning of the junction within the active site, as shown for T7 endonuclease I.
Architectural roles and higher-order assemblies
In simple terms: Some proteins bind four-way junctions to organize DNA architecture rather than to cut it.
Architectural proteins such as HMG-box factors bind four-way junctions without catalyzing cleavage, instead serving to bend DNA and facilitate the assembly of nucleoprotein complexes. This binding can compete with or modulate the activity of resolvases, thereby influencing recombination outcomes. The affinity of these proteins for four-way junctions is often comparable to their affinity for other distorted DNA structures, suggesting a general role in DNA packaging and repair.
Supramolecular recognition and synthetic mimics
In simple terms: Synthetic molecules can be designed to recognize four-way junctions, mimicking natural proteins.
Recent work has demonstrated that an M2L4 metallo-cage can selectively recognize a DNA four-way junction, inspired by simulation-guided design. This highlights the potential for creating artificial receptors that target Holliday junctions for therapeutic or diagnostic purposes. Such studies also provide insights into the fundamental principles of four-way junction recognition.
Key Genes Involved in GO:0000400 four-way junction DNA binding
The following genes and proteins are representative examples of factors that bind or process four-way junction DNA, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| HMGB1 | HMG-box architectural protein that binds four-way junctions | Model for sequence-independent junction binding and chromatin remodeling |
| HMGB2 | HMG-box protein with similar junction-binding activity | Studied for roles in DNA repair and recombination |
| T7 endonuclease I | Resolvase that cleaves Holliday junctions | Structural paradigm for junction recognition and cleavage |
| RuvC | E. coli Holliday junction resolvase | Bacterial model for junction resolution |
| RuvA | E. coli Holliday junction binding protein | Component of the RuvABC resolvasome |
| RuvB | ATPase that drives branch migration | Part of the RuvABC complex |
| Lambda integrase | Site-specific recombinase that forms and resolves Holliday junctions | Model for bacteriophage lambda recombination |
| GEN1 | Human Holliday junction resolvase | Implicated in DNA repair and genome stability |
| SLX1-SLX4 | Human structure-specific nuclease complex | Resolves Holliday junctions in recombination |
| MUS81-EME1 | Human structure-specific endonuclease | Processes branched DNA intermediates |
| BLM | RecQ helicase that dissolves Holliday junctions | Defective in Bloom syndrome |
| WRN | RecQ helicase with junction-processing activity | Defective in Werner syndrome |
| RAD51 | Recombinase that forms Holliday junctions | Central to homologous recombination |
| RAD54 | Chromatin remodeler that stimulates RAD51 | Facilitates recombination |
| BRCA1 | Tumor suppressor involved in recombination | Mutations linked to breast and ovarian cancer |
| BRCA2 | Tumor suppressor that loads RAD51 | Mutations linked to cancer predisposition |
| FANCM | Fanconi anemia protein that processes junctions | Roles in DNA repair and replication |
How Is four-way junction DNA binding Regulated?
The activity of four-way junction DNA binding proteins is regulated at multiple levels. Post-translational modifications such as phosphorylation and ubiquitination can modulate their affinity for junctions or their subcellular localization. For example, the human resolvase GEN1 is regulated by phosphorylation, which affects its activity during the cell cycle. Additionally, the availability of cofactors such as ATP and divalent metal ions influences the catalytic processing of junctions by resolvases. In the context of bacteriophage lambda recombination, the assembly of the recombinogenic complex is tightly regulated by accessory proteins and DNA supercoiling.
four-way junction DNA binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| BRCA1 | Hereditary breast and ovarian cancer | Knockout cell lines (e.g., HeLa, MCF10A) to study recombination defects |
| BRCA2 | Hereditary breast and ovarian cancer | Knock-in of patient mutations in iPSCs |
| BLM | Bloom syndrome | Knockout HEK293T cells for sister chromatid exchange assays |
| WRN | Werner syndrome | Point-mutation knock-in in fibroblasts |
| FANCM | Fanconi anemia | Knockout in hematopoietic stem cells |
Cancer and genomic instability
Defects in proteins that bind or resolve four-way junctions, such as GEN1, SLX4, and BRCA1/2, are associated with increased genomic instability and cancer predisposition. Loss of these functions can lead to unresolved Holliday junctions, chromosomal breaks, and aneuploidy, driving tumorigenesis. For example, mutations in BRCA1 and BRCA2 impair homologous recombination and are linked to hereditary breast and ovarian cancer.
Bloom syndrome and Werner syndrome
Bloom syndrome and Werner syndrome are caused by mutations in the BLM and WRN helicases, respectively, which play roles in processing Holliday junctions and branched DNA structures. Cells from these patients exhibit elevated sister chromatid exchange and genomic instability, highlighting the importance of junction-processing activities in maintaining genome integrity.
Fanconi anemia
The Fanconi anemia pathway involves proteins such as FANCM that bind and process DNA junctions during replication stress. Defects in this pathway lead to Fanconi anemia, a disorder characterized by bone marrow failure and cancer susceptibility.
From four-way junction DNA binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X bind four-way junctions in vivo? | Tagged knock-in (e.g., GFP) followed by ChIP or imaging |
| What is the catalytic mechanism of resolvase Y? | Point mutation of active-site residues in knockout background |
| Does overexpression of HMG-box protein alter recombination? | Overexpression cell lines and reporter assays |
| Is the junction-binding domain essential for function? | Domain-deletion knockout via CRISPR |
| How does a disease-associated mutation affect junction binding? | Knock-in of the mutation in isogenic cell lines |
| Can a synthetic molecule compete with protein binding? | In vitro binding assays with purified proteins and metallo-cages |
How to Study the four-way junction DNA binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| EMSA | Protein-DNA binding affinity and specificity | Characterizing architectural protein binding to junctions |
| FRET | Conformational changes and dynamics | Real-time monitoring of junction bending |
| X-ray crystallography | Atomic structure of protein-DNA complex | Detailed mechanism of resolvase binding |
| Cleavage assay | Enzymatic resolution of junctions | Measuring resolvase activity |
| Single-molecule imaging | Dynamic behavior of individual complexes | Studying branch migration and cleavage |
| Atomic force microscopy | Visualization of DNA-protein complexes | Observing junction binding in vitro |
| Surface plasmon resonance | Real-time binding kinetics | Quantifying affinity of synthetic molecules |
| Isothermal titration calorimetry | Thermodynamics of binding | Determining binding enthalpy and entropy |
Electrophoretic mobility shift assay (EMSA)
EMSA is a classic method to detect protein binding to four-way junction DNA. A radiolabeled or fluorescently labeled junction is incubated with purified protein, and the resulting complexes are resolved on native polyacrylamide gels [1, 8]. This assay can determine binding affinity and specificity, and is used to study architectural proteins and resolvases [1, 7].
FRET and single-molecule imaging
Fluorescence resonance energy transfer (FRET) can monitor conformational changes in four-way junctions upon protein binding. By labeling specific arms of the junction with fluorophores, researchers can observe bending, stacking, or cleavage in real time [3, 8]. Single-molecule FRET provides dynamic insights into junction recognition and processing.
X-ray crystallography and cryo-EM
High-resolution structures of protein-four-way junction complexes reveal the molecular details of recognition and catalysis. For example, the crystal structure of T7 endonuclease I bound to a junction showed how the protein distorts the DNA. Cryo-EM is increasingly used for larger complexes.
Biochemical cleavage assays
To measure resolvase activity, four-way junctions are incubated with the enzyme, and cleavage products are analyzed by denaturing gel electrophoresis [5, 7]. This method is used to characterize the catalytic mechanism and the effects of mutations.
How CRISPR Can Be Used to Study GO:0000400 four-way junction DNA binding
Knockout
CRISPR knockout of genes encoding four-way junction binding proteins (e.g., GEN1, BLM) can reveal their roles in DNA repair and recombination. Knockout cell lines are generated by introducing frameshift mutations in early exons, followed by validation of protein loss and functional assays such as sensitivity to DNA-damaging agents.
Point Mutation
Point mutations can be introduced to dissect the catalytic or binding residues of a junction-binding protein. For example, mutating the active-site tyrosine of a resolvase to phenylalanine abolishes cleavage while retaining binding, allowing separation of binding and catalysis.
Knock-in
Knock-in of disease-associated mutations (e.g., BRCA1 missense variants) into isogenic cell lines enables the study of how these mutations affect four-way junction processing and genome stability. Tagged knock-in (e.g., GFP or HA) facilitates localization and interaction studies.
Overexpression
Overexpression of architectural proteins like HMGB1 can be achieved by CRISPR activation or lentiviral delivery. This allows researchers to study the effects of excess junction-binding activity on chromatin structure and recombination.
How EDITGENE Supports four-way junction DNA binding Research
Researchers studying four-way junction DNA binding-related genes often need to determine whether a candidate gene is causally involved in recombination, DNA repair, or disease. EDITGENE provides a comprehensive suite of CRISPR services to create precisely engineered cell models, enabling functional validation of genes encoding four-way junction binding proteins.
Contact EDITGENE today to design your custom CRISPR model for four-way junction DNA binding research.
Frequently Asked Questions About four-way junction DNA binding
What is four-way junction DNA binding?
Four-way junction DNA binding (GO:0000400) is the molecular function of binding to a DNA segment containing a Holliday junction, a structure where two DNA double strands are held together by reciprocal exchange of two strands.
What genes are involved in four-way junction DNA binding?
Genes encoding HMG-box proteins (e.g., HMGB1, HMGB2), resolvases (e.g., GEN1, RuvC), and helicases (e.g., BLM, WRN) are involved in four-way junction DNA binding [1, 5].
What is the role of Holliday junction binding in DNA repair?
Holliday junction binding is essential for homologous recombination and DNA double-strand break repair, as it allows proteins to process and resolve recombination intermediates.
How is four-way junction DNA binding studied?
Common methods include electrophoretic mobility shift assays (EMSA), FRET, X-ray crystallography, and cleavage assays [1, 3, 5, 7].
What diseases are associated with defects in four-way junction DNA binding?
Defects in junction-binding proteins are linked to cancer predisposition (e.g., BRCA1/2 mutations), Bloom syndrome, Werner syndrome, and Fanconi anemia.
What is the difference between four-way junction DNA binding and Holliday junction resolution?
Binding refers to the recognition and interaction with the junction, while resolution involves cleavage of the junction by resolvases to separate the DNA strands.
Can four-way junction DNA binding be targeted for therapy?
Yes, synthetic molecules such as metallo-cages can be designed to recognize four-way junctions, offering potential for therapeutic or diagnostic applications.
What is the structure of a four-way DNA junction?
The four-way DNA junction adopts a stacked-X conformation in solution, with two coaxial helical stacks and a central exchange region.
Which proteins are known to bind four-way junctions without cleaving them?
Architectural proteins such as HMG-box factors (e.g., HMGB1) bind four-way junctions without catalyzing cleavage, playing roles in chromatin organization.
How can CRISPR be used to study four-way junction DNA binding?
CRISPR can create knockouts, point mutations, knock-ins, and overexpression models of genes encoding junction-binding proteins to dissect their functions in recombination and disease.
Conclusion
Four-way junction DNA binding (GO:0000400) is a fundamental molecular function that underpins homologous recombination, DNA repair, and chromatin architecture. The interplay between architectural proteins and resolvases at Holliday junctions ensures genome stability, and defects in these processes lead to cancer and genetic disorders [1, 5]. Continued research using advanced structural and biochemical methods, as well as CRISPR-based models, will further illuminate the mechanisms and therapeutic potential of targeting four-way junction DNA binding [3, 4, 8].
References
- 1. Zlatanova J et al.. 1998. Binding to four-way junction DNA: a common property of architectural proteins?. FASEB J 12(6):421-31 PMID: 9535214
- 2. Zhao Z et al.. 2024. DNA four-way junction-driven dual-rolling circle amplification sandwich-type aptasensor for ultra-sensitive and specific detection of tumor-derived exosomes.. Biosens Bioelectron 246:115841 PMID: 38006701
- 3. Duckett DR et al.. 1995. Structure of the four-way DNA junction and its interaction with proteins.. Philos Trans R Soc Lond B Biol Sci 347(1319):27-36 PMID: 7746850
- 4. Dettmer SJ et al.. 2025. Supramolecular Recognition of a DNA Four-Way Junction by an M(2)L(4) Metallo-Cage, Inspired by a Simulation-Guided Design Approach.. Angew Chem Int Ed Engl 64(26):e202504866 PMID: 40243103
- 5. Wyatt HD et al.. 2014. Holliday junction resolvases.. Cold Spring Harb Perspect Biol 6(9):a023192 PMID: 25183833
- 6. Van Duyne GD et al.. 2024. Bacteriophage lambda site-specific recombination.. Mol Microbiol 121(5):895-911 PMID: 38372210
- 7. Déclais AC et al.. 2003. The complex between a four-way DNA junction and T7 endonuclease I.. EMBO J 22(6):1398-409 PMID: 12628932
- 8. McGorman B et al.. 2023. Analysis of non-canonical three- and four-way DNA junctions.. Methods 219:30-38 PMID: 37690737
